GWMIA
CATX icon

Global Wealth Management Investment Advisory’s Perspective Therapeutics CATX Stock Holding History

Global Wealth Management Investment Advisory’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-50
Closed – – 691
2019
Q1 		$0 Hold
50
– – ﹤0.01% 680
2018
Q4 		$0 Buy
+50
New +$214 ﹤0.01% 696

Other funds holding CATX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HPWM
Highland Private Wealth Management Bellevue, Washington $620M AUM 18.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
CWM
Cahaba Wealth Management Atlanta, Georgia $1.47B AUM 13.36% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $5.94B AUM 18.44% 1-Year Est. Return

Global Wealth Management Investment Advisory's CATX Position: Q2 2019 in Review

Global Wealth Management Investment Advisory sold out of Perspective Therapeutics (CATX) in Q2 2019, closing a stake of 50 shares.

Global Wealth Management Investment Advisory first reported a position in CATX in Q4 2018 and held it in 2 quarters. The position peaked at $0 in Q1 2019. 29 funds tracked by Wall St. Rank hold CATX as of Q2 2019.

  • Global Wealth Management Investment Advisory reported no remaining Perspective Therapeutics position as of Q2 2019 after selling out during the quarter.
  • Global Wealth Management Investment Advisory sold 50 Perspective Therapeutics shares in Q2 2019.
  • Global Wealth Management Investment Advisory first reported a position in Perspective Therapeutics in Q4 2018 and held it in 2 quarters.
  • Global Wealth Management Investment Advisory's Perspective Therapeutics position peaked at $0 in Q1 2019.
  • 29 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q2 2019.

Based on Global Wealth Management Investment Advisory's 13F filing for Q2 2019, filed 20 Aug 2019.